
Borteshil 2mg Injection
Marketer
Shilpa Medicare Ltd
Salt Composition
Bortezomib (2mg)
Overview Borteshil 2mg Injection
Myeloma and mantle cell lymphoma are treated with the injectable medication, Bortezomib 2mg. Its mechanism of action involves inhibiting or retarding cancerous cell proliferation. Administration is exclusively by injection from a qualified healthcare provider. Dosage and frequency are determined by your physician based on your condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; improper use or overdosage can result in severe adverse effects. Therapeutic benefits might not be apparent for weeks or months; discontinue only upon medical instruction. Common side effects include fatigue, nausea, vomiting, and anorexia. Increased fluid intake is often recommended. Operating machinery or driving should be avoided due to potential drowsiness and dizziness. This medication can lower blood cell counts (red and white blood cells), increasing infection risk. Regular blood tests are necessary to monitor blood cell levels, along with cardiac, hepatic, and uric acid levels. Pre-existing liver, kidney, or heart disease, or bleeding disorders should be disclosed to your doctor before commencing treatment. Report any cognitive symptoms, such as memory impairment or difficulty concentrating, immediately. Inform your healthcare team of all other medications you are taking, as interactions may occur. This medication is contraindicated during pregnancy and lactation. Reliable contraception is crucial for both partners throughout the treatment period to prevent conception.
Uses of Borteshil 2mg Injection
Myeloma and mantle cell lymphoma
Major Benefits of Borteshil 2mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Borteshil 2mg Injection:
- Low blood platelets
- Fatigue
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Psychiatric disturbances
- Nausea
- Vomiting
- Loss of appetite
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased appetite
- Decreased white blood cell count (neutrophils)
- Constipation
How to use Borteshil 2mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
How Borteshil 2mg Injection works:
Borteshil 2mg Injection is an anticancer agent that inhibits the degradation of cellular proteins. This accumulation of proteins within cancer cells ultimately triggers their demise.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Borteshil 2mg Injection and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Borteshil 2mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in life-threatening circumstances where a physician deems the potential benefits outweigh the inherent dangers. Always seek medical advice before use.
Breast feedingUNSAFE
Administering Borteshil 2mg Injection while breastfeeding is contraindicated. Available evidence indicates potential infant toxicity.
DrivingUNSAFE
Administering Borteshil 2mg Injection may induce adverse reactions impacting driving capabilities. These reactions can include drowsiness, vertigo, syncope, or visual disturbances, potentially impairing safe driving.
KidneyCAUTION
Administering Borteshil 2mg Injection to individuals with severe renal impairment requires careful consideration. Dosage modification of Borteshil 2mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Borteshil 2mg Injection. Dosage modification for Borteshil 2mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Borteshil 2mg Injection :
Omit doses of Borteshil 2mg Injection only after speaking with your physician.
Facts to Know About Borteshil 2mg Injection
| Label | Value |
|---|---|
| Chemical Type | Phenylalanine-based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
